| Revenue By Product Type |
United States revenue by product type is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
September 30, | | Nine Months Ended
September 30, | | 2025 | | 2024 | | 2025 | | 2024 | | Open ablation | $ | 35,592 | | $ | 30,601 | | $ | 105,368 | | $ | 90,661 | | Minimally invasive ablation | 7,428 | | 11,117 | | 23,747 | | 35,263 | | Pain management | 20,837 | | 16,314 | | 59,275 | | 44,059 | | | | | | | | | | Appendage management | 45,450 | | 37,420 | | 132,649 | | 111,257 | | Total United States | $ | 109,307 | | $ | 95,452 | | $ | 321,039 | | $ | 281,240 |
International revenue by product type is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
September 30, | | Nine Months Ended
September 30, | | | 2025 | | 2024 | | 2025 | | 2024 | | Open ablation | $ | 10,852 | | $ | 8,607 | | $ | 30,196 | | $ | 25,679 | | Minimally invasive ablation | 1,862 | | 1,681 | | 6,247 | | 5,559 | | Pain management | 2,080 | | 1,590 | | 5,902 | | 3,768 | | | | | | | | | | Appendage management | 10,168 | | 8,580 | | 30,644 | | 24,784 | | Total International | $ | 24,962 | | $ | 20,458 | | $ | 72,989 | | $ | 59,790 |
|
| Revenue By Geographic Area |
Revenue attributed to customer geographic locations is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
September 30, | | Nine Months Ended
September 30, | | 2025 | | 2024 | | 2025 | | 2024 | | United States | $ | 109,307 | | $ | 95,452 | | $ | 321,039 | | $ | 281,240 | | | | | | | | | | Europe | 15,170 | | 12,215 | | 45,501 | | 36,193 | | Asia Pacific | 8,083 | | 6,914 | | 22,351 | | 19,916 | | Other International | 1,709 | | 1,329 | | 5,137 | | 3,681 | | Total International | 24,962 | | 20,458 | | 72,989 | | 59,790 | | Total Revenue | $ | 134,269 | | $ | 115,910 | | $ | 394,028 | | $ | 341,030 |
|